Doses: Difference between revisions
Jump to navigation
Jump to search
updated dose table with values from PhD theses |
|||
Line 17: | Line 17: | ||
|- | |- | ||
|A4 | |A4 | ||
| | |1200-1300 <ref name="Kringhoej" /> | ||
|700 | |700 | ||
| | |900 <ref name="Hertel" /> | ||
|630 | |630 | ||
|? | |? | ||
Line 26: | Line 26: | ||
|1200 | |1200 | ||
|? | |? | ||
| | |900-920 <ref name="Hertel" /> | ||
|760 | |760 | ||
|? | |? | ||
|- | |- | ||
| | |EL6 | ||
|? | |? | ||
|? | |? | ||
Line 37: | Line 37: | ||
|? | |? | ||
|- | |- | ||
| | |EL9 | ||
| | |450-500 <ref name="Kringhoej">[https://nbi.ku.dk/english/theses/phd-theses/anders-kringhoej/Anders_Kringhoej_PhD.pdf Kringhøj PhD thesis]</ref> | ||
|? | |? | ||
|280 <ref name="Hertel" /> | |||
|420 | |420 | ||
|? | |? | ||
Line 52: | Line 52: | ||
|- | |- | ||
|CSAR9 | |CSAR9 | ||
| | |500 <ref name="Kringhoej" /> | ||
|? | |? | ||
|? | |? | ||
Line 59: | Line 59: | ||
|- | |- | ||
|CSAR13 | |CSAR13 | ||
| | |430 <ref name="Kringhoej" /> | ||
|? | |? | ||
|? | |? | ||
Line 68: | Line 68: | ||
|? | |? | ||
|? | |? | ||
| | |500 <ref name="Hertel" /> | ||
|745 | |745 | ||
|? | |? | ||
Line 87: | Line 87: | ||
|900 | |900 | ||
|? | |? | ||
| | |620 <ref name="Drachmann" /> | ||
|? | |? | ||
|1500-1600 <ref name="Ansaloni" /> | |||
|- | |- | ||
|A4 | |A4 | ||
|900 | |900 | ||
| | |640-680 <ref name="Whiticar">[https://nbi.ku.dk/english/theses/phd-theses/alexander-m-whiticar/Whiticar_thesis.pdf Whiticar PhD thesis]</ref> | ||
| | |608-640 <ref name="Drachmann">[https://nbi.ku.dk/english/theses/phd-theses/asbjorn-cliff-drachmann/Drachmann_PhD_Thesis.pdf/Drachmann_PhD_Thesis.pdf Drachmann PhD thesis]</ref> | ||
|630 | |630 | ||
| | |900 <ref name="Ansaloni">[https://nbi.ku.dk/english/theses/phd-theses/fabio-ansaloni/thesis_Ansaloni.pdf Ansaloni PhD thesis]</ref> | ||
|- | |- | ||
|A6 | |A6 | ||
Line 105: | Line 105: | ||
|? | |? | ||
|- | |- | ||
| | |EL6 | ||
|? | |? | ||
|? | |? | ||
Line 112: | Line 112: | ||
|? | |? | ||
|- | |- | ||
| | |EL9 | ||
|? | |? | ||
|? | |? | ||
|380 <ref name="Hertel">[https://nbi.ku.dk/english/theses/phd-theses/hertel/dissertation_Hertel.pdf Hertel PhD thesis]</ref> | |||
|200 <ref name="Drachmann" /> | |||
|? | |? | ||
|- | |- | ||
Line 124: | Line 124: | ||
|? | |? | ||
|? | |? | ||
| | |335 <ref name="Ansaloni" /> | ||
|- | |- | ||
|CSAR9 | |CSAR9 | ||
Line 131: | Line 131: | ||
|? | |? | ||
|? | |? | ||
| | |335 <ref name="Ansaloni" /> | ||
|- | |- | ||
|CSAR13 | |CSAR13 |
Revision as of 13:37, 2 February 2022
Si | InAsUC | InPUC | GaAsUC | SiGe | |
A2 | 1000 | 700 | ? | ? | ? |
A4 | 1200-1300 [1] | 700 | 900 [2] | 630 | ? |
A6 | 1200 | ? | 900-920 [2] | 760 | ? |
EL6 | ? | ? | ? | ? | ? |
EL9 | 450-500 [1] | ? | 280 [2] | 420 | ? |
CSAR4 | 430 | ? | ? | ? | ? |
CSAR9 | 500 [1] | ? | ? | ? | ? |
CSAR13 | 430 [1] | ? | ? | 350 | ? |
50k+A4 | ? | ? | 500 [2] | 745 | ? |
Si | InAsUC | InPUC | GaAsUC | SiGe | |
A2 | 900 | ? | 620 [3] | ? | 1500-1600 [4] |
A4 | 900 | 640-680 [5] | 608-640 [3] | 630 | 900 [4] |
A6 | 1000 | ? | ? | 670 | ? |
EL6 | ? | ? | ? | ? | ? |
EL9 | ? | ? | 380 [2] | 200 [3] | ? |
CSAR4 | 400 | ? | ? | ? | 335 [4] |
CSAR9 | ? | ? | ? | ? | 335 [4] |
CSAR13 | ? | ? | ? | ? | ? |
50k+A4 | ? | ? | ? | 630 | ? |
- GaAs: Uniform clearing
- InP: Uniform clearing
- InAs: Uniform clearing
- Si: Optimal contrast
Note
Base dose does not change with resist thickness, developing time does. However, if the developing time is fixed, say to 60s, a thinner layer of resist will need lower "base dose", since it's being over developed.
Experimental
- Dose density matrix for small and large spot size.
- Measure CD as a function of dose and density for the two spot sizes.
- Intersection of the two plots, for a given density gives isofocal dose.
- Convert doses to dose factors, given that 0% iso-dose factor == PEC_df 0%
- Base dose == isofocal dose 0% / PEC_df 0%
- For density larger than 0%, predicted dose factor = (1+η)/(1+η*ρ*(1+φ/100))
- 1+η = PEC_df 0%
- Fit experimental isofocal dose factors and predicted dose factor by varying psi
100 kV:
Si: 897 uC/cm2 and phi = 75%
125 kV:
InP: 572 uC/cm2 and phi = 41%
InAs: 589 uC/cm2 and phi = 33%
Si: 906 uC/cm2 and phi = 45%
GaAs:752 uC/cm2 and phi = 39%
Si (μC/cm2) / φ | InAs (μC/cm2) / φ | InP (μC/cm2) / φ | GaAs (μC/cm2) / φ | SiGe (μC/cm2) / φ | |
A2 | ? | ? | ? | ? | ? |
A4 | 897 / 75% | ? | ? | ? | ? |
A6 | ? | ? | ? | ? | ? |
El6 | ? | ? | ? | ? | ? |
El9 | ? | ? | ? | ? | ? |
CSAR4 | ? | ? | ? | ? | ? |
CSAR9 | ? | ? | ? | ? | ? |
CSAR13 | ? | ? | ? | ? | ? |
50k+A4 | ? | ? | ? | ? | ? |
Si (μC/cm2) / φ | InAs (μC/cm2) / φ | InP (μC/cm2) / φ | GaAs (μC/cm2) / φ | SiGe (μC/cm2) / φ | |
A2 | ? | ? | ? | ? | ? |
A4 | 906/ 45% | 589/ 33% | 572/ 41% | 752/ 39% | ? |
A6 | ? | ? | ? | ? | ? |
El6 | ? | ? | ? | ? | ? |
El9 | ? | ? | ? | ? | ? |
CSAR4 | ? | ? | ? | ? | ? |
CSAR9 | ? | ? | ? | ? | ? |
CSAR13 | ? | ? | ? | ? | ? |
50k+A4 | ? | ? | ? | ? | ? |